Two-part dialyzer with reusable housing reduces plastic waste
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current dialyzer systems generate significant plastic waste and are labor-intensive and risky to reprocess, as the entire unit is typically discarded after use, with the housing being inseparably connected to blood-contacting parts.
Innovation Solution
A two-part dialyzer design where blood-contacting components form a first element without housing and dialysis fluid-contacting components form a second element with housing, allowing the housing to be reused and cleaned, while blood-contacting parts are disposed of, reducing plastic waste and microbiological risks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the entire dialyzer is discarded after use, then patient safety is ensured by eliminating contamination risks, but plastic waste is significantly generated
Solution Approach 1:
The dialyzer is divided into two separable parts: a reusable housing (second element) and a disposable blood-contacting component (first element). This segmentation allows the non-contaminated housing to be recovered and reused multiple times, reducing plastic waste while the blood-contacting part is discarded to ensure patient safety.
Solution Approach 2:
The housing component is designed to be recovered and reused after the blood-contacting element is discarded. The housing can be cleaned and disinfected between uses, enabling multiple treatment sessions from a single housing unit while minimizing overall plastic waste.
2Device complexity
If the housing is inseparably connected to blood-contacting parts, then structural simplicity is maintained, but reprocessing becomes labor-intensive and microbiologically risky
Solution Approach 1:
The dialyzer is divided into two separable parts: a reusable housing (second element) and a disposable blood-contacting component (first element). This segmentation allows the non-contaminated housing to be recovered and reused multiple times, reducing plastic waste while the blood-contacting part is discarded to ensure patient safety.
Solution Approach 2:
The blood-contacting first element is extracted as a separate removable component from the housing. This extraction allows the housing to be easily separated for reuse while the contaminated element can be quickly removed and discarded, streamlining the reprocessing workflow.
3Ease of operation
If the sheathing film is removed after housing insertion, then dialysis fluid flow is improved, but the housing cannot be easily reopened for reprocessing
Solution Approach 1:
The dialyzer is divided into two separable parts: a reusable housing (second element) and a disposable blood-contacting component (first element). This segmentation allows the non-contaminated housing to be recovered and reused multiple times, reducing plastic waste while the blood-contacting part is discarded to ensure patient safety.
Solution Approach 2:
The housing is designed with a dynamic opening/closing mechanism that allows it to be opened for inserting the blood-contacting element during assembly, then closed for use, and reopened for reprocessing. This dynamic design enables the housing to adapt to different operational states while maintaining fluid flow during dialysis.
Data Source
AI summary
A housing-free first dialyzer element has a hollow-fiber bundle, a fluid-permeable sheath wrapped around the periphery of the hollow-fiber bundle, cast elements at the axial ends of the hollow-fiber bundle, and end caps fastened to the cast elements for connection to an extracorporeal blood circulation. A second dialyzer element has a housing and can be closed, opened and reused. A dialyzer includes the housing-free first dialyzer element and the second dialyzer element that has a housing. A blood treatment device includes the second dialyzer element that has the housing, the second dialyzer element being rigidly fastened to a machine front. A method for reprocessing the second dialyzer element that has the housing can be used after blood treatment therapy.


